Education
About Us
Working with TipRanks
Follow Us
Ankit Mahadevia Insider Profile
4 Followers
Ankit Mahadevia, Director at Spero Therapeutics, holds 709.87K shares in Spero Therapeutics (Ticker: SPRO).
Profitable Transactions
3 out of 5 Profitable Transactions
Average Return
-52.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Ankit Mahadevia's holdings
Insider Roles
Director
Roles that Ankit Mahadevia holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Feb 05, 2024 - Feb 05, 2025
Return:+39.00%
The most profitable trade made by Ankit Mahadevia
Ankit Mahadevia's Trading History
List of latest transactions for each holding click on a transaction to see Ankit Mahadevia's performance on stock
You May Also Like
Ankit Mahadevia insider profile FAQ
What is the percentage of profitable transactions made by Ankit Mahadevia?
The percentage of profitable transactions made by Ankit Mahadevia is 60%.
What is the average return per transaction made by Ankit Mahadevia?
The average return per transaction made by Ankit Mahadevia is -52.00%.
What stocks does Ankit Mahadevia hold?
Ankit Mahadevia holds: SPRO stocks.
What was Ankit Mahadevia’s latest transaction?
Ankit Mahadevia latest transaction was an Uninformative Buy of ―.
What was Ankit Mahadevia's most profitable transaction?
Ankit Mahadevia’s most profitable transaction was an Informative Sell of SPRO stock on February 5, 2024. The return on the trade was 39.00%.
What is Ankit Mahadevia's role in Spero Therapeutics?
Ankit Mahadevia's role in Spero Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.